Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography.
about
Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysisNeuroimaging of cerebrovascular disease in the aging brain.Quantitative assessment of rest and acetazolamide CBF using quantitative SPECT reconstruction and sequential administration of (123)I-iodoamphetamine: comparison among data acquired at three institutions.Effect of acupuncture on cerebrovascular reserve in patients with acute cerebral infarction: protocol for a randomized controlled pilot study.Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease.Recent developments regarding human immunodeficiency virus infection and stroke.Improved cerebrovascular reactivity following low flow EC/IC bypass in patients with occlusive carotid disease.Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients."Imaging Evaluation of Collaterals in the Brain: Physiology and Clinical Translation"Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease.Combination of blood flow asymmetry in the cerebral and cerebellar hemispheres on brain perfusion SPECT predicts 5-year outcome in patients with symptomatic unilateral major cerebral artery occlusion.Total cerebral blood flow estimated by color velocity imaging quantification ultrasound: a predictor for recurrent stroke?Management of patients with atherosclerotic carotid occlusion.Effect of cilostazol administration on cerebral hemodynamics and rehabilitation outcomes in poststroke patients.
P2860
Q27693840-EAD9CA72-AF1A-4D12-AF90-1B098E45EA90Q30460557-971E74B1-AB42-47B9-B8B4-F158D9382136Q30835467-6B2FAAFC-4934-4A61-AFAB-3C646F45E9B5Q33830406-59F5D958-2D8B-424C-9C28-C0EA3AAB4F85Q35560468-180689C5-F9BC-41C7-8D0C-7C4665C5383DQ37977280-B4404735-A552-4097-92ED-E36FCE09C3D9Q39894182-E7A83A95-D37F-416F-A4A9-29DE36A2BD6BQ39932185-33D85CCF-A21D-488A-83F0-FB4698B1E84EQ43046054-3A364037-9AF2-4A9F-B025-98D4E84B421DQ45141087-05283629-77B6-4F8D-84D1-4202F4263194Q45991239-588B53A5-08A6-4F0F-B99D-1E5EC7AE59ADQ48417790-A9CF6CBB-14B5-4D11-BB0E-30E825DE40FDQ51011622-69C08E95-B611-4044-A834-0CC0805B0C8BQ51812524-BC6844A4-F513-4679-94CA-CAF67DC90529
P2860
Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of cerebrovascular reactiv ...... emission computed tomography.
@en
Use of cerebrovascular reactiv ...... emission computed tomography.
@nl
type
label
Use of cerebrovascular reactiv ...... emission computed tomography.
@en
Use of cerebrovascular reactiv ...... emission computed tomography.
@nl
prefLabel
Use of cerebrovascular reactiv ...... emission computed tomography.
@en
Use of cerebrovascular reactiv ...... emission computed tomography.
@nl
P2093
P2860
P1476
Use of cerebrovascular reactiv ...... emission computed tomography.
@en
P2093
Akira Ogawa
Hiroaki Shimizu
Kazunori Terasaki
Kuniaki Ogasawara
Takashi Yoshimoto
Teiji Tominaga
P2860
P304
P356
10.1097/00004647-200209000-00012
P577
2002-09-01T00:00:00Z
P5875
P6179
1018258678